Listed by the USPTO as KANE, TREVOR LOGAN
Tech Center 1700 • Art Units: 1651 1657 1699 1791
This examiner grants 69% of resolved cases
KANE, TREVOR LOGAN is assigned to tech center 1700 and art unit 1651. The profile covers 112 resolved cases, with an allowance rate of 68.8% and a median of 1227 days to allowance. Interviews correspond to a 53.3% lift in the recorded allowance rate. That association gives interview preparation a meaningful role in prosecution strategy for matters in this record.
The listed companies are CJ CheilJedang Corporation, The Johns Hopkins University, and The Regents of the University of California. Listed firms include AMSTER, ROTHSTEIN & EBENSTEIN LLP, Armis Intellectual Property Law, LLC, and GREENBLUM & BERNSTEIN, P.L.C. The available case volume supports directional use of the figures. Practitioners should integrate interview planning with claim development and realistic timing expectations.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18579156 | NOVEL BETA-CAROTENE 15,15-OXYGENASE VARIANT AND RETINOID PRODUCTION METHOD USING SAME | Non-Final OA | CJ CHEILJEDANG CORPORATION |
| 18300014 | ANASTASIS BIOSENSOR | Non-Final OA | THE JOHNS HOPKINS UNIVERSITY |
| 17931704 | COMPOSITIONS AND METHODS FOR TREATING CELIAC SPRUE DISEASE | Non-Final OA | The Regents of the University of California |
| 18861952 | A METHOD OF CELL REJUVENATION | Non-Final OA | Evonik Operations GmbH |
| 17749555 | Non-Transgenic Functional Rescue of Neuropeptides | Final Rejection | Worcester Polytechnic Institute |
| 18110934 | ENGINEERED PROTEIN DELIVERY PLATFORM AND USE THEREOF FOR ANTIBACTERIAL TREATMENTS | Final Rejection | RAMOT AT TEL AVIV UNIVERSITY LTD. |
| 18573368 | LACCASE | Final Rejection | AMANO ENZYME INC. |
| 18039514 | MODIFICATION OF SAPONINS | Non-Final OA | GLAXOSMITHKLINE BIOLOGICALS SA |
| 18587045 | NON-TOXIN-PRODUCING ASPERGILLUS FLAVUS STRAIN, MICROBIAL INOCULANT, PREPARATION, AND USE | Non-Final OA | Xiangyang Academy of Agricultural Sciences |
| 18552468 | VARIANTS OF RHIZOMUCOR MIEHEI LIPASE AND USES THEREOF | Final Rejection | WILMAR INTERNATIONAL LIMITED |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy68.8% of resolved applications examined by Trevor Logan Kane were allowed (112 resolved cases), compared with 31.6% across Art Unit 1651 over the last five years.
This examiner's interview lift is +53.3 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Trevor Logan Kane took 1,227 days on average from filing to allowance.
Trevor Logan Kane examines applications in Art Unit 1651 in Tech Center 1700 (Chemistry & Materials).
